Point-of-Care Testing (POCT) Market

Point-of-Care Testing (POCT) Market Size, Share, Growth Analysis, By Product Type(Covid -19 testing kits, Glucose monitoring products), By Platform(Lateral Flow Assays, Dipsticks), By Mode of Purchase(OTC products, Prescribed based products), By Testing Type(Immunoassays, Cell-Based Assays), By End-User(Clinical laboratories, Ambulatory care facilities and physician offices), By Geography(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35B2172 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Point-of-Care Testing (POCT) Market Insights

Market Overview:

The global point-of-care testing (POCT) market has experienced significant growth, with an estimated value of USD 40.6 billion in 2021. It is projected to continue expanding at a robust Compound Annual Growth Rate (CAGR) of 10.92% from 2022 to 2030, with an anticipated value of around USD 103.2 billion by the end of the forecast period. This remarkable growth can be attributed to the rising prevalence of various disorders among the global population, which has led to an increased demand for rapid and accurate diagnostic solutions at the point of care. POCT offers several advantages, including reduced turnaround time, enhanced patient outcomes, and increased accessibility to healthcare services, driving its adoption in both developed and developing regions. As technological advancements continue to improve the efficiency and reliability of POCT devices, the market is poised for substantial growth in the coming years.

Point-of-Care Testing (POCT) Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Supplies by segment aggregation, the contribution of the Health Care Supplies in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Point-of-Care Testing (POCT) was estimated to be valued at US$ XX Mn in 2021.

The global Point-of-Care Testing (POCT) Market is estimated to grow at a CAGR of XX% by 2028.

The global Point-of-Care Testing (POCT) Market is segmented on the basis of Product Type, Platform, Mode of Purchase, Testing Type, End-User, Geography.

Based on region, the global Point-of-Care Testing (POCT) Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Point-of-Care Testing (POCT) Market are , Sinocare Inc , Hoffmann La Roche Ltd , Siemens AG , Abott Laboratories , bioMrieux SA , Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC , Mankind pharma , OraSure Technologies, inc , A. Menarini Diagnostics s.r.l , ACON Laboratories , Trinity Biotech plc.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Point-of-Care Testing (POCT) Market

Product ID: UCMIG35B2172

$5,300
BUY NOW GET FREE SAMPLE